Edition:
United States

Therapy Cells Inc (TCEL.PK)

TCEL.PK on OTC Markets Group

0.00USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,129,718
52-wk High
$0.00
52-wk Low
$0.00

Chart for

About

Therapy Cells, Inc. is a development-stage company. The Company's business operations consist of doing business in the cell repair and cell replacement for Equine stock. The Company is pursuing Food and Drug Administration (FDA) approval for existing and modified products to be used for the repair of the human body. The... (more)
No analyst recommendations are available for .

Overall

Beta: 4.78
Market Cap(Mil.): $0.15
Shares Outstanding(Mil.): 1,533.80
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

Earnings vs. Estimates

No consensus analysis data available.